Abstract:HighlightsThere is big concern about reflux appearance after sleeve gastrectomy.Chronic reflux increases risk of esophageal adenocarcinoma.We present a case of an esophageal adenocarcinoma after sleeve gastrectomy.Relationship between sleeve gastrectomy and reflux needs further study.
“…Another case reported by Sohn [ 9 ] described esophageal adenocarcinoma 2.5 years after SG also without previous endoscopic evaluation. In a recent publication, Wright [ 10 ] described esophageal adenocarcinoma five years after SG in a patient with normal previous preoperative gastroscopy. Our case is the only one with BE without dysplasia detected before SG.…”
HighlightsLiterature evidences regarding the evolution of Barrett’s esophagus after sleeve gastrectomy is poor and the relation between sleeve gastrectomy and the development of subsequent esophageal cancer isn’t clear yet.Preoperative upper endoscopy should be performed in order to detect gastroesophageal reflux disease, Barrett’s esophagus, before undergoing bariatric surgery. Post operative monitoring of the upper gastrointestinal tract after sleeve gastrectomy is essential.
“…Another case reported by Sohn [ 9 ] described esophageal adenocarcinoma 2.5 years after SG also without previous endoscopic evaluation. In a recent publication, Wright [ 10 ] described esophageal adenocarcinoma five years after SG in a patient with normal previous preoperative gastroscopy. Our case is the only one with BE without dysplasia detected before SG.…”
HighlightsLiterature evidences regarding the evolution of Barrett’s esophagus after sleeve gastrectomy is poor and the relation between sleeve gastrectomy and the development of subsequent esophageal cancer isn’t clear yet.Preoperative upper endoscopy should be performed in order to detect gastroesophageal reflux disease, Barrett’s esophagus, before undergoing bariatric surgery. Post operative monitoring of the upper gastrointestinal tract after sleeve gastrectomy is essential.
“…One should add that Barrett's metaplasia can be found in only 1.6% of the average population [21]. Esophageal adenocarcinoma after SG has been reported in a small number of cases [22,23]. For instance, El Khoury et al published a case report of esophageal adenocarcinoma in BE found even 3 years after SG [24].…”
Section: Barrett's Esophagus After Sleeve Gastrectomymentioning
Background Laparoscopic sleeve gastrectomy (SG) is the most frequently performed bariatric procedure today. While an increasing number of long-term studies report the occurrence of Barrett's esophagus (BE) after SG, its treatment has not been studied, yet. Objectives The aim of this study was to evaluate Roux-en-Y gastric bypass (RYGB) as treatment for BE and reflux after SG. Setting University hospital setting, Austria Methods This multi-center study includes all patients (n = 10) that were converted to RYGB due to BE after SG in Austria. The mean interval between SG and RYGB was 42.7 months. The follow-up after RYGB in this study was 33.4 months. Gastroscopy, 24 h pH-metry, and manometry were performed and patients were asked to complete the BAROS and GIQLI questionnaires. Results Weight and BMI at the time of SG was 120.8 kg and 45.1 kg/m 2. Eight patients (80.0%) went into remission of BE after the conversion to RYGB. Two patients had RYGB combined with hiatoplasty. The mean acid exposure time in 24 h decreased from 36.8 to 3.8% and the mean DeMeester score from 110.0 to 16.3. Patients scored 5.1 on average in the BAROS after conversion from SG to RYGB which denotes a very good outcome. Conclusions RYGB is an effective therapy for patients with BE and reflux after SG. Its outcomes in the current study were BE remission in the majority of cases as well as a decrease in reflux activity. Further studies with larger cohorts are necessary to confirm these findings.
“…Several reports have stated an increased risk of Barrett's esophagus and increased GERD after SG [13,14]. To our knowledge 3 cases of esophageal adenocarcinoma have been reported after SG [15]. According to the International Sleeve Gastrectomy Expert Panel Consensus Statement severe esophagitis and Barrett's esophagus are contraindications for SG.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.